Literature DB >> 7582561

Relationship between inhibition of cyclic AMP production in Chinese hamster ovary cells expressing the rat D2(444) receptor and antagonist/agonist binding ratios.

E A Harley1, D N Middlemiss, C I Ragan.   

Abstract

1. Radioligand binding assays using [3H]-(-)-sulpiride, in the presence of 1 mM ethylenediaminetetraacetic acid (EDTA) and 100 microM guanylylimidodiphosphate (GppNHp) and [3H]-N0437 were developed to label the low and high agonist affinity states of the rD2(444) receptor (long form of the rat D2 receptor) respectively. The ratios of the affinities of compounds in these two assays (Kapp [3H]-(-)-supiride/Kapp [3H]-N-0437) were then calculated. 2. The prediction that the binding ratio reflected the functional efficacy of a compound was supported by measurement of the ability of a number of compounds acting at dopamine receptors to inhibit rD2(444)-mediated inhibition of cyclic AMP production. When the rank order of the ratios of a number of these compounds was compared to their ability to inhibit the production of cyclic AMP, a significant correlation was seen (Spearman rank correlation coefficient = 0.943, P = 0.01). 3. In conclusion, the sulpiride/N-0437 binding ratio reliably predicted the efficacy of compounds acting at dopamine receptors to inhibit cyclic AMP production mediated by the rD2(444) receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582561      PMCID: PMC1908776          DOI: 10.1111/j.1476-5381.1995.tb15041.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  Relative affinities of drugs acting at cholinoceptors in displacing agonist and antagonist radioligands: the NMS/Oxo-M ratio as an index of efficacy at cortical muscarinic receptors.

Authors:  S B Freedman; E A Harley; L L Iversen
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

3.  The character of the muscarinic receptors in different regions of the rat brain.

Authors:  N J Birdsall; E C Hulme; A Burgen
Journal:  Proc R Soc Lond B Biol Sci       Date:  1980-02-13

4.  Cloning and expression of a rat D2 dopamine receptor cDNA.

Authors:  J R Bunzow; H H Van Tol; D K Grandy; P Albert; J Salon; M Christie; C A Machida; K A Neve; O Civelli
Journal:  Nature       Date:  1988 Dec 22-29       Impact factor: 49.962

5.  A novel short isoform of the D3 dopamine receptor generated by alternative splicing in the third cytoplasmic loop.

Authors:  C S Fishburn; D Belleli; C David; S Carmon; S Fuchs
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

6.  Differences in the ligand binding properties of the short and long versions of the D2 dopamine receptor.

Authors:  S W Castro; P G Strange
Journal:  J Neurochem       Date:  1993-01       Impact factor: 5.372

Review 7.  Recent advances in the molecular biology of dopamine receptors.

Authors:  J A Gingrich; M G Caron
Journal:  Annu Rev Neurosci       Date:  1993       Impact factor: 12.449

8.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

9.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

10.  The dopamine D2 receptor: two molecular forms generated by alternative splicing.

Authors:  R Dal Toso; B Sommer; M Ewert; A Herb; D B Pritchett; A Bach; B D Shivers; P H Seeburg
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  1 in total

1.  Investigation on quantitative structure activity relationships and pharmacophore modeling of a series of mGluR2 antagonists.

Authors:  Meng-Qi Zhang; Xiao-Le Zhang; Yan Li; Wen-Jia Fan; Yong-Hua Wang; Ming Hao; Shu-Wei Zhang; Chun-Zhi Ai
Journal:  Int J Mol Sci       Date:  2011-09-16       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.